81
edits
Supply Chain Issues: Difference between revisions
→Introduction
| Line 3: | Line 3: | ||
The COVID-19 pandemic precipitated a global disruption of supply chains and led to significant global supply shortages in various medicines and health-related products. Shortages and struggles for access disproportionately affected vulnerable populations, including those with chronic illnesses, low-income individuals, and marginalised communities. | The COVID-19 pandemic precipitated a global disruption of supply chains and led to significant global supply shortages in various medicines and health-related products. Shortages and struggles for access disproportionately affected vulnerable populations, including those with chronic illnesses, low-income individuals, and marginalised communities. | ||
The situation exacerbates existing global health inequities.<ref>Haldane, V., De Foo, C., Abdalla, S.M. et al. Health systems resilience in managing the COVID-19 pandemic: lessons from 28 countries. Nat Med 27, 964–980 (2021). https://doi.org/10.1038/s41591-021-01381-y</ref> Whilst shortages | The situation exacerbates existing global health inequities.<ref>Haldane, V., De Foo, C., Abdalla, S.M. et al. Health systems resilience in managing the COVID-19 pandemic: lessons from 28 countries. Nat Med 27, 964–980 (2021). https://doi.org/10.1038/s41591-021-01381-y</ref> Whilst supply shortages, uncertain medical stocks and counterfeit medical essentials are global problems, developed countries experience disruptions in supply chains for medications that were previously available, whilst lower income countries face chronic shortages and limited access to essential drugs, and others historically lacked access to certain essential medications. | ||
===Ongoing Supply Chain Challenges=== | ===Ongoing Supply Chain Challenges=== | ||